Healthy volunteers test new mental health drug in early safety study
NCT ID NCT06702332
First seen Sep 30, 2025 · Last updated May 10, 2026 · Updated 25 times
Summary
This early-stage study tested a new drug called MSD-001 in 47 healthy adults to see if it is safe and how the body processes it. Participants took a single dose of the drug or a placebo. The goal was not to treat any condition, but to gather important safety information for future research.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MENTAL HEALTH DISORDERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centre for Human Drug Research
Leiden, South Holland, Netherlands
Conditions
Explore the condition pages connected to this study.